A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery

Gynecologic Oncology

Volumn 139, Issue 3, 2015, Pages 433-438

  Angioli, Roberto ^a   Plotti, Francesco ^a   Aloisi, Alessia ^a   Scaletta, Giuseppe ^a   Capriglione, Stella ^a   Luvero, Daniela ^a   Fiore, Laura ^a   Terranova, Corrado ^a   Montera, Roberto ^a   Panici, Pierluigi Benedetti ^b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adjuvant chemotherapy; Cervical cancer; Randomized controlled trial

Indexed keywords

CISPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOSAGE SCHEDULE COMPARISON; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROTOXICITY; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE CERVIX CANCER; VOMITING; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CHEMICALLY INDUCED; CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA; COMPARATIVE STUDY; LYMPH NODE METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING; SECONDARY; SURVIVAL RATE; TUMOR RECURRENCE; UTERINE CERVICAL NEOPLASMS;

ADENOCARCINOMA; ADULT; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 84949645564     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.09.082     Document Type: Article

References (34)

1. J. Ferlay, I. Soerjomataram, M. Ervik, and et al. GLOBOCAN 2012 v1. 0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 2012 International Agency for Research Lyon, France ([on-line], http://globocan.iarc.fr)
2. H.M. Keys, B.N. Bundy, F.B. Stehman, and et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma N. Engl. J. Med. 340 15 1999 1154 1161
3. M. Morris, P.J. Eifel, J. Lu, and et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer N. Engl. J. Med. 340 1999 1137 1143
4. W.A. Peters III, P.Y. Liu, R. Barrett, and et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J. Clin. Oncol. 18 2000 1606 1613
5. P.G. Rose, B.N. Bundy, E.B. Watkins, and et al. Concurrent cisplatin-based chemoradiation improves progression-free survival in advanced cervical cancer: results of a randomized Gynecologic Oncology Group study N. Engl. J. Med. 340 1999 1144 1153
6. C.W. Whitney, W. Sause, B.N. Bundy, and et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study J. Clin. Oncol. 17 5 1999 339 348
7. P. Benedetti-Panici, S. Greggi, A. Colombo, and et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J. Clin. Oncol. 20 2002 179 188
8. A. Dueñas-González, J.J. Zarbá, and et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix J. Clin. Oncol. 29 2011 1678 1685
9. J.E. Sardi, M.A. Boixadera, and J.J. Sardi Neoadjuvant chemotherapy in cervical cancer: a new trend Curr. Opin. Obstet. Gynecol. 17 2005 43 47
10. B. Mossa, S. Mossa, and R. Marziani Adjuvant chemotherapy versus radiation therapy after radical surgery in high-risk positive node stage IB/IIA cervical cancer Eur. J. Gynaecol. Oncol. 31 2010 545 550
11. N. Takeshima, K. Umayahara, K. Fujiwara, and et al. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer Gynecol. Oncol. 103 2006 618 622
12. R. Angioli, F. Plotti, R. Montera, and et al. Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer Gynecol. Oncol. 127 2012 290 296
13. J.A. Green, J.M. Kirwan, J.F. Tierney, and et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis Lancet 358 2001 781 786
14. C. Sananes, A. Giaroli, and A. Soderini Neoadjuvant chemotherapy followed by radical hysterectomy and postoperative adjuvant chemotherapy in the treatment of carcinoma of the cervix uteri: long-term follow-up of a pilot study Eur. J. Gynaecol. Oncol. 19 1998 368 373
15. J.E. Sardi, A. Giaroli, C. Sananes, and et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results Gynecol. Oncol. 67 1997 61 69
16. R. Angioli, D. Luvero, A. Aloisi, and et al. Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature. Expert. Rev. Anticancer. Ther. 14 2014 431 439
17. Chemoradiotherapy for cervical cancer meta-analysis, Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials J. Clin. Oncol. 26 2008 5802 5812
18. L. Gong, J.Y. Lou, P. Wang, and et al. Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer Int. J. Gynaecol. Obstet. 117 2012 23 26
19. M. Hosaka, H. Watari, T. Kato, and et al. Clinical efficacy of paclitaxel/cisplatin as an adjuvant chemotherapy for patients with cervical cancer who underwent radical hysterectomy and systematic lymphadenectomy J. Surg. Oncol. 105 2012 612 616
20. M. Lahousen, J. Haas, and H. Pickel Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: a randomized, prospective, multicenter trial Gynecol. Oncol. 73 1999 196 201
21. H. Lukka, H. Hirte, A. Fyles, and et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer - a meta-analysis. Clin. Oncol. (R. Coll. Radiol.) 14 2002 203 212
22. J. Green, J. Kirwan, J. Tierney, and et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix Cochrane Database Syst. Rev. 3 2005 CD002225
23. D. Lorusso, F. Petrelli, A. Coinu, and et al. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer Gynecol. Oncol. 133 2014 117 123
24. H.S. Kim, J.E. Sardi, N. Katsumata, and et al. Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis Eur. J. Surg. Oncol. 39 2013 115 124
25. National Comprehensive Cancer Network (NCCN), Clinical Practice Guidelines in Oncology, Cervical Cancer.
26. World Health Organization, WHO Handbook for Reporting Results of Cancer Treatment (offset publication no. 48) Geneva, Switzerland 1979 16 21
27. S. Dische Radiotherapy of cervical cancer Clin. Obstet. Gynecol. 12 1985 203 227
28. J.F. Barter, S.J. Soong, H.M. Shingleton, and et al. Complications of combined radical hysterectomy - postoperative radiation therapy in women with early stage cervical cancer Gynecol. Oncol. 32 1989 292 296
29. B.J. Monk, D.S. Cha, J.L. Walker, and et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma Gynecol. Oncol. 54 1994 4 9
30. Peters WA, Liu PY, Barrett RGW et al. Cisplatin,5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high risk, early stage carcinoma of cervix after radical hysterectomy and pelvic lymphadenectomy: report of phase III inter group study. Presented at: Soc Gynecol Oncol 30th Annual Meeting. San Francisco, CA, USA, 5-9 February 19
31. T. Iwasaka, T. Kamura, M. Yokoyama, and et al. Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma: a comparison with effects of adjuvant radiotherapy Obstet. Gynecol. 91 1998
32. R.C. Young, and et al. Three cycles versus six cycles of adjuvant paclitaxel (taxol)/carboplatin in early stage ovarian cancer Semin. Oncol. 27 2000 8 10
33. K.S. Tewari, M.W. Sill, H.J. Long 3rd, and et al. Improved survival with bevacizumab in advanced cervical cancer N. Engl. J. Med. 370 2014 734 743
34. R.T. Penson, H.Q. Huang, L.B. Wenzel, and et al. Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240) Lancet Oncol. 16 2015 301 311